HL
CELG

HeadInvest LLC’s Celgene Corp CELG Stock Holding History

HeadInvest LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,245
Closed -$620K – 201
2019
Q3 		$620K Sell
6,245
-1,945
-24% -$185K 0.19% 85
2019
Q2 		$757K Sell
8,190
-3,107
-28% -$295K 0.21% 75
2019
Q1 		$1.07M Sell
11,297
-11,863
-51% -$1.04M 0.3% 63
2018
Q4 		$1.48M Buy
23,160
+1,450
+7% +$107K 0.24% 73
2018
Q3 		$1.94M Sell
21,710
-1,190
-5% -$105K 0.56% 48
2018
Q2 		$1.82M Sell
22,900
-485
-2% -$40.3K 0.55% 48
2018
Q1 		$2.09M Buy
23,385
+755
+3% +$72.5K 0.67% 46
2017
Q4 		$2.36M Sell
22,630
-490
-2% -$55.3K 0.73% 44
2017
Q3 		$2.33M Buy
23,120
+175
+0.8% +$23.8K 0.73% 43
2017
Q2 		$2.98M Buy
22,945
+140
+0.6% +$17.2K 0.98% 33
2017
Q1 		$2.84M Sell
22,805
-240
-1% -$28.7K 0.95% 34
2016
Q4 		$2.67M Sell
23,045
-55
-0.2% -$6.13K 0.99% 35
2016
Q3 		$2.41M Buy
23,100
+1,700
+8% +$184K 0.85% 37
2016
Q2 		$2.11M Buy
21,400
+775
+4% +$80.2K 0.8% 42
2016
Q1 		$2.06M Buy
20,625
+1,650
+9% +$170K 0.81% 41
2015
Q4 		$2.27M Buy
18,975
+845
+5% +$97.8K 0.92% 36
2015
Q3 		$1.96M Buy
+18,130
New +$2.25M 0.79% 41

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

HeadInvest LLC's CELG Position: Q4 2019 in Review

HeadInvest LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,245 shares — an estimated $620K sold.

HeadInvest LLC first reported a position in CELG in Q3 2015 and held it in 17 quarters. The position peaked at $2.98M in Q2 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HeadInvest LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HeadInvest LLC sold 6,245 Celgene Corp shares in Q4 2019, an estimated $620K.
  • HeadInvest LLC first reported a position in Celgene Corp in Q3 2015 and held it in 17 quarters.
  • HeadInvest LLC's Celgene Corp position peaked at $2.98M in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HeadInvest LLC's 13F filing for Q4 2019, filed 14 Feb 2020.